ALBI联合剩余肝体积对HBV相关原发性肝癌患者肝切除术后肝衰竭发生的预测价值*

doi:10.3969/j.issn.1672-5069.2020.04.033

摘要/Abstract

摘要： 目的评价联合应用白蛋白-胆红素(ALBI)评分和剩余肝体积(FLR)预测肝细胞癌(HCC)患者发生肝切除术后肝功能衰竭(PHLF)的价值。方法 2015年10月～2019年5月我院收治的HCC患者76例,术前行腹部三维CT重建,由软件计算全肝体积和剩余肝体积(FLR),行白蛋白-胆红素(ALBI)评分,均接受肝切除术。采用单因素和多因素Logistic回归分析影响HCC患者发生PHLF的相关因素,应用受试者工作特征曲线(ROC)分析,确定PHLF发生的独立预测因素。结果在76例HCC患者中发生PHLF 28例,未发生PHLF 48例;非PHLF组年龄为(48.2±6.3)岁,显著小于PHLF组[(55.9±7.1)岁,P<0.05],INR为(0.9±0.1),显著低于PHLF组[(1.1±0.1),P<0.05],血清白蛋白为(40.6±3.2)g/L,显著高于PHLF组[(36.4±3.1)g/L,P<0.05],血小板计数为(241.2±80.3)×10⁹/L,显著高于PHLF组[(181.9±60.8)×10⁹/L,P<0.05],ALBI评分为(-2.9±0.8)分,显著低于PHLF组[(-1.8±1.0)分,P<0.05],MELD评分为(7.0±1.5)分,显著低于PHLF组[(8.4±1.9)分,P<0.05],Child-Pugh评分为(4.2±1.2)分,显著低于PHLF组[(5.8±1.4)分,P<0.05],FLR为(890.6±210.6)cm³,显著大于PHLF组[(720.1±180.7)cm³,P<0.05];多因素Logistic回归分析提示ALBI评分和FLR是HCC患者发生PHLF的独立预测因素(P<0.05);ALBI联合FLR诊断HCC患者发生PHLF的敏感度和特异度分别为81.2%和90.5%。结论联合应用ALBI和FLR评估HCC患者肝脏储备功能有助于防止PHLF的发生,对提高手术成功率有重要的临床意义。

关键词: 肝细胞癌, 肝切除术, 术后肝功能衰竭, 血清白蛋白-胆红素评分, 剩余肝体积, Logistic回归分析

Abstract: Objective The purpose of this study was to evaluate the value of albumin-bilirubin (ALBI) score and future liver remnant (FLR) combination in predicting the occurrence of post-hepatectomy liver failure (PHLF) in patients with hepatocellular carcinoma (HCC). Methods A total of 76 patients with HCC were recuited in our hospital between October 2015 and May 2019, and ALBI were obtained. All the patients underwent abdominal three-dimensional CT reconstruction and hepatectomy. Univariate and multivariate Logistic regression analysis were applied to explore the clinical influencing factors related to the occurrence of PHLF. The diagnostic values of the related index for the occurrence of PHLF were determined by receiver operating characteristic curve. Results Out of the 76 patients with HCC, 28 had PHLF and 48 hadn’t; the average age of patients with non-PHLF was (48.2±6.3) years, significantly younger than [(55.9±7.1) years, P<0.05], the INR was (0.9±0.1), significantly lower than [(1.1±0.1), P <0.05], serum albumin level was (40.6±3.2) g/L, significantly higher than [(36.4±3.1) g/L, P <0.05], blood platelet count was (241.2±80.3)×10⁹/l, significantly higher than [(181.9±60.8)×10⁹/l, P<0.05], the ALBI score was (-2.9±0.8), significantly lower than [(-1.8±1.0), P <0.05], the MELD score was (7.0±1.5), significantly lower than that [(8.4±1.9), P <0.05], the Child-Pugh score was (4.2±1.2), significantly lower than [(5.8±1.4), P <0.05], and the FLR was (890.6±210.6)cm³, significantly larger than [(720.1±180.7)cm³, P <0.05]in patients without PHLF; multivariate Logistic regression analysis showed that ALBI score and and FLR were the independent predictors of PHLF occurrence in patients with HCC (P <0.05); the sensitivity and specificity of ALBI and FLR combination in diagnosing PHLF in patients with HCC were 81.2% and 90.5%. Conclusion The application of ALBI and FLR for evaluating liver reserve function in patients with HCC before hepatectomy is feasible, and might guide the clinicians to make decisions and prevent the occurrence of PHLF.

Key words: Hepatocellular carcinoma, Post-hepatectomy liver failure, Albumin-bilirubin score, Future liver remnant, Logistic regression analysis

冯涛, 胡伟, 滕步伟, 李伟. ALBI联合剩余肝体积对HBV相关原发性肝癌患者肝切除术后肝衰竭发生的预测价值^*[J]. 实用肝脏病杂志, 2020, 23(4): 585-588.

Feng Tao, Hu Wei, Teng Buwei, et al. Value of ALBI and future liver remnant combinationin predicting the occurrence of post-hepatectomy liver failure in patients with hepatocellular carcinoma[J]. Journal of Practical Hepatology, 2020, 23(4): 585-588.

参考文献

[1]Zhao Y, Wang WJ, Guan S, et al.Sorafenib combined with transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma: a large-scale multicenter study of 222 patients. Ann Oncol, 2013, 24(7):1786-1792.
[2]Li Z, Jiao D, Han X, et al.Transcatheter arterial chemoembolization combined with simultaneous DynaCT-guided microwave ablation in the treatment of small hepatocellular carcinoma. Cancer Imaging, 2020, 20(1):13.
[3]Zhong X, Tang H, Lu B, et al.Differentiation of small hepatocellular carcinoma from dysplastic nodules in cirrhotic liver: texture analysis based on MRI improved performance in comparison over gadoxetic acid-enhanced MR and diffusion-weighted imaging. Front Oncol, 2020, 9:1382.
[4]Kong FH, Miao XY, Zou H, et al. End-stage liver disease score and future liver remnant volume predict post-hepatectomy liver failure in hepatocellular carcinoma. World J Clin Cases, 2019, 7(22):3734-3741.
[5]Gong WF, Zhong JH, Lu Z, et al.Evaluation of liver regenescoren and post-hepatectomy liver failure after hemihepatectomy in patients with hepatocellular carcinoma. Biosci Rep, 2019, 39(8):2231-2235.
[6]Chin KM, Allen JC, Teo JY, et al.Predictors of post-hepatectomy liver failure in patients undergoing extensive liver resections for hepatocellular carcinoma. Ann Hepatobiliary Pancreat Surg, 2018, 22(3):185-196.
[7]Zhang ZQ, Xiong L, Zhou JJ, et al. Ability of the ALBI grade to predict posthepatectomy liver failure and long-term survival after liver resection for different BCLC stages of HCC. World J Surg Oncol, 2018, 16(1):208.
[8]Wang YY, Zhong JH, Su ZY, et al. Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma. Br J Surg, 2016, 103(6):725-734.
[9]Dello SA, Stoot JH, van Stiphout RS, et al. Prospective volumetric assessment of the liver on a personal computer by nonradiologists prior to partial hepatectomy. World J Surg, 2011, 35(2):386-392.
[10]Vouche M, Lewandowski RJ, Atassi R, et al. Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. J Hepatol, 2013, 59(5):1029-1036.
[11]Kim HJ, Kim CY, Park EK, et al. Volumetric analysis and indocyanine green retention rate at 15 min as predictors of post-hepatectomy liver failure. HPB, 2015, 17(2):159-167.
[12]Kishi Y, Abdalla EK, Chun YS, et al. Three hundred and one consecutive extended right hepatectomies.Ann Surg, 2009, 250:540-548.
[13]Balzan S, Belghiti J, Farges O, et al. The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg, 2005, 242(6):824-828.
[14]Rahbari NN, Garden OJ, Padbury R, et al.Posthepatectomy liver failure: a definiction and grading by the International Study Group of Liver Surgery(ISGLS). Surgery, 2011, 149(5):713-724.
[15]Ishigami M, Honda T, Okumura A, et al. Use of the model for end-stage liver disease (MELD) score to predict 1-year survival of Japanese patients with cirrhosis and to determine who will benefit from living donor liver transplantation. J Gastroenterol, 2008, 43(5):363-368.
[16]Fragaki M, Sifaki-Pistolla D, Orfanoudaki E, et al.Comparative evaluation of ALBI, MELD, and Child-Pugh scores in prognosis of cirrhosis: is ALBI the new alternative? Ann Gastroenterol, 2019, 32(6):626-632.
[17]Krige J, Spence RT, Jonas E, et al. A new recalibrated four-category Child-Pugh score performs better than the original Child-Pugh and MELD scores in predicting in-hospital mortality in decompensated alcoholic cirrhotic patients with acute variceal bleeding: a real-world cohort analysis. World J Surg, 2020, 44(1):241-246.
[18]Iakova P, Awad SS, Timchenko NA. Aging reduces proliferative capacities of liver by switching pathways of C/EBPalpha growth arrest. Cell, 2003, 113(4): 495-506.
[19]孙惠川, 汤敏, 钦伦秀, 等. 用余肝体积预测半肝切除耐受性的安全标准. 中华肝胆外科杂志, 2006,32(6):366-369.
[20]Heinemann A, Wischhusen F, Püschel K, et al. Standard liver volume in the Caucasian population. Liver Transpl Surg, 1999, 5(5):366-368.
[21]Schiano TD, Bodian C, Schwartz ME, et al. Accuracy and significance of computed tomographic scan assessment of hepatic volume in patients undergoing liver transplantation. Transplantation, 2000, 69(4):545-550.

ALBI联合剩余肝体积对HBV相关原发性肝癌患者肝切除术后肝衰竭发生的预测价值^*

Value of ALBI and future liver remnant combinationin predicting the occurrence of post-hepatectomy liver failure in patients with hepatocellular carcinoma

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	张静, 周新民. 应用重组人血小板生成素减少肝硬化患者术前血小板输注疗效初步研究^*[J]. 实用肝脏病杂志, 2020, 23(4): 552-555.
[2]	顾世玉, 秦文举, 高建芝, 薛明辉. 肝细胞癌癌组织Hic-5和COL1A1表达及其对术后生存的预测价值^*[J]. 实用肝脏病杂志, 2020, 23(4): 576-580.
[3]	崔喆,徐兰. 基于多数据库分析肝细胞癌组织FAM49B基因水平及其临床意义[J]. 实用肝脏病杂志, 2020, 23(3): 413-418.
[4]	徐学清,李炳超,冯铠莉. CT增强纹理技术对TACE治疗的原发性肝癌患者术后肿瘤短期进展的预测价值[J]. 实用肝脏病杂志, 2020, 23(3): 423-426.
[5]	王亮亮,杨波,张卫国. 荧光腹腔镜肝切除术与常规腹腔镜肝切除术治疗HCC患者效果比较[J]. 实用肝脏病杂志, 2020, 23(3): 427-430.
[6]	王玮, 杜晓菲, 路运健. 术前NLR水平对TACE联合MWA治疗的巨块型原发性肝癌患者生存时间的影响^*[J]. 实用肝脏病杂志, 2020, 23(2): 260-263.
[7]	李天纵, 周松, 周石. 肝细胞癌患者TACE治疗前后血清miR-145水平变化及其临床意义[J]. 实用肝脏病杂志, 2020, 23(2): 264-267.
[8]	胡鸿, 廖运国, 魏欣, 唐梓瑜, 邓丹, 蒲嘉骐, 钟立明. ¹²⁵I粒子植入或3DCRT联合TACE治疗晚期原发性肝癌患者临床疗效对比研究^*[J]. 实用肝脏病杂志, 2020, 23(2): 268-271.
[9]	刘潇, 何年安, 叶显俊, 刘力, 付文学, 陈姣姣. 超声造影对肝细胞癌与肝转移癌的鉴别诊断价值分析[J]. 实用肝脏病杂志, 2020, 23(1): 94-97.
[10]	石莹莹, 王元喜. 应用肝脏影像报告与数据管理系统诊断肝细胞癌的价值研究^*[J]. 实用肝脏病杂志, 2020, 23(1): 98-101.
[11]	马宁, 戴晓雯, 吴建江. 肝部分切除术患者目标导向性液体治疗疗效及安全性研究^*[J]. 实用肝脏病杂志, 2020, 23(1): 102-105.
[12]	高莉, 高屹, 尹秋萍. CT灌注成像联合彩色多普勒超声造影辨别肝脏结节性病变性质临床价值探讨^*[J]. 实用肝脏病杂志, 2020, 23(1): 106-109.
[13]	曹策, 郁义星, 王贝贝, 赵卫峰. 增强磁共振成像联合血清甲胎蛋白和脱-γ-羧基凝血酶原诊断肝细胞癌临床价值探讨[J]. 实用肝脏病杂志, 2019, 22(6): 896-899.
[14]	金震, 周晓春, 马红霞. 椎旁阻滞联合全身麻醉对肝血管瘤切除术患者疼痛及术后恢复的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 908-911.
[15]	黎秋曦, 贾健锋, 黄锐. 区段肝蒂肝切除术与B超引导下肝切除术治疗肝胆管结石患者临床价值分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 916-919.